Drummer Olaf H
Victorian Institute of Forensic Medicine and Department of Forensic Medicine, Monash University, 57-83 Kavanagh Street, Southbank, Melbourne 3006, Australia.
Forensic Sci Int. 2005 Jun 10;150(2-3):133-42. doi: 10.1016/j.forsciint.2004.11.022. Epub 2005 Apr 18.
This article reviews studies that have measured drug concentrations in oral fluid following controlled dosing regimens. A total of 23 studies have been identified over the last 15 years. These show that the amphetamines including designer amphetamines, cocaine, cannabis and cocaine are quickly found in oral fluid following dosing and usually have similar time-courses to that in plasma. Following common doses peak oral fluid concentrations exceed 0.1 microg/mL and often even 1 microg/mL. The drug concentration will depend on whether a dilution step occurs with buffer as part of the sampling procedure. The uses of collectors that stimulate oral fluid usually reduce the drug concentration compared to a non-stimulated manner. This reduction will not disadvantage the recipient since it will potentially reduce the detectability of drug in oral fluid compared to non-stimulated collections. Only one recent study has been reported for a benzodiazepine. This showed nanogram per milliliter concentrations for flunitrazepam. More studies are required for benzodiazepines and indeed for other drugs, particularly in multiple drug situations and where disease may affect the pharmacokinetics of drugs.
本文综述了在控制给药方案后测量口腔液中药物浓度的研究。在过去15年中总共确定了23项研究。这些研究表明,包括合成苯丙胺类兴奋剂、可卡因、大麻和可卡因在内的苯丙胺类药物在给药后能迅速在口腔液中被检测到,并且其时间进程通常与血浆中的相似。服用常见剂量后,口腔液中的药物峰值浓度超过0.1微克/毫升,甚至常常超过1微克/毫升。药物浓度将取决于采样过程中是否使用缓冲液进行稀释步骤。与未刺激的方式相比,使用刺激口腔液分泌的采集器通常会降低药物浓度。这种降低对采集者并无不利影响,因为与未刺激采集相比,它可能会降低口腔液中药物的可检测性。关于苯二氮䓬类药物,仅报道了一项近期研究。该研究显示氟硝西泮的浓度为每毫升纳克级。对于苯二氮䓬类药物以及其他药物,确实需要进行更多研究,尤其是在多种药物联合使用的情况下以及疾病可能影响药物药代动力学的情况下。